Related Experiment Video

Updated: Jun 25, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Targeting mTOR-dependent tumours with specific inhibitors: a model for personalized medicine based on molecular

L Furic, M Livingstone, R J O Dowling

    Current Oncology (Toronto, Ont.)
    |February 21, 2009
    PubMed

    Insights

    Targeting the mammalian target of rapamycin (mTOR) pathway shows promise for cancer treatment. New inhibitors may offer more effective tumor growth inhibition than current drugs.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Pharmacology

    Background:

    • Cancer is driven by uncontrolled cell growth due to disrupted signaling pathways.
    • The mammalian target of rapamycin (mTOR) pathway is a key regulator of cell growth, integrating various signals.
    • Aberrant mTOR signaling is implicated in numerous human cancers.

    Purpose of the Study:

    • To review the efficacy of targeting the mTOR pathway in cancer therapy.
    • To discuss the rationale for developing novel mTOR inhibitors.
    • To highlight potential improvements in tumor growth inhibition with next-generation drugs.

    Main Methods:

    • Literature review of preclinical and clinical studies on mTOR inhibitors in cancer.
    • Analysis of signaling mechanisms regulated by the mTOR pathway.
    • Evaluation of the mechanisms of action for first-generation and novel mTOR inhibitors.

    Main Results:

    • First-generation mTOR inhibitors have demonstrated clinical activity in various cancers.
    • Understanding mTOR pathway deregulation provides a basis for targeted therapy.
    • Emerging mTOR inhibitors exhibit enhanced potency and selectivity.

    Conclusions:

    • Targeting the mTOR pathway is a validated strategy in cancer treatment.
    • Next-generation mTOR inhibitors hold significant promise for improved therapeutic outcomes.
    • Further research into mTOR pathway modulation is crucial for advancing cancer therapy.
    Keywords:
    Cell signallingFkbp12Lkb1mtorrapamycintumour growth

    More Related Videos

    Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor09:33

    Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

    Published on: August 25, 2023

    Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing09:24

    Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

    Published on: June 9, 2016

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    Mouse Models of Cancer Study02:43

    Mouse Models of Cancer Study

    Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
    The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...